Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -67.13% is 90% below its 5-year average of -35.38%, near the low end of its 5-year range (-67.13%–-20.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.89% below its 12-month average of -51.29%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -67.13%.
RETURN ON INVESTED CAPITAL (ROIC)
-67.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-35.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-34.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-34.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-30.89%
CURRENT VS 3Y AVG
-59.27%
CURRENT VS 5Y AVG
-89.75%
CURRENT VS 10Y AVG
-93.08%
CURRENT VS 15Y AVG
-93.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-88.34%
vs the sector median at left
Kura Oncology, Inc.
Market Cap
$934.79M
Return on Invested Capital (ROIC)
-67.13%
TTM Avg
-51.29%
3Y Avg
-42.15%
5Y Avg
-35.38%
Market Cap
$929.83M
Return on Invested Capital (ROIC)
-36.95%
TTM Avg
-36.95%
3Y Avg
-36.95%
5Y Avg
-36.95%
Market Cap
$923.53M
Return on Invested Capital (ROIC)
-46.54%
TTM Avg
-25.88%
3Y Avg
-39.60%
5Y Avg
-39.60%
Market Cap
$921.06M
Return on Invested Capital (ROIC)
-50.77%
TTM Avg
-47.91%
3Y Avg
-50.09%
5Y Avg
-281.80%
Market Cap
$952.91M
Return on Invested Capital (ROIC)
-82.30%
TTM Avg
-52.55%
3Y Avg
-42.51%
5Y Avg
-41.57%
Market Cap
$953.81M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$914.73M
Return on Invested Capital (ROIC)
4.96%
TTM Avg
4.19%
3Y Avg
3.59%
5Y Avg
3.20%
Market Cap
$973.93M
Return on Invested Capital (ROIC)
1.35%
TTM Avg
-1.75%
3Y Avg
1.09%
5Y Avg
1.96%
Market Cap
$978.09M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $934.79M | -67.13% | -51.29% | -42.15% | -35.38% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | -36.95% | -36.95% | -36.95% | -36.95% |
| CeriBell, Inc. (CBLL)vs › | $923.53M | -46.54% | -25.88% | -39.60% | -39.60% |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | -50.77% | -47.91% | -50.09% | -281.80% |
| Savara Inc. (SVRA)vs › | $952.91M | -82.30% | -52.55% | -42.51% | -41.57% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -16.54% | -24.45% | -23.43% | -23.43% |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 4.96% | 4.19% | 3.59% | 3.20% |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 1.35% | -1.75% | 1.09% | 1.96% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | -25.25% | -75.69% | -67.13% | -61.15% |
ROIC
-67.1%
ROE
-612.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -67.13% |
| 2026-03-31 | -57.53% |
| 2025-12-31 | -48.76% |
| 2025-09-30 | -45.04% |
| 2025-06-30 | -37.99% |
| 2025-03-31 | -31.02% |
| 2024-12-31 | -28.24% |
| 2024-09-30 | -49.41% |
| 2024-06-30 | -41.47% |
| 2024-03-31 | -35.21% |
| 2023-12-31 | -40.08% |
| 2023-09-30 | -34.55% |
| 2023-06-30 | -31.50% |
| 2023-03-31 | -35.32% |
| 2022-12-31 | -32.36% |
| 2022-09-30 | -32.55% |
| 2022-06-30 | -29.73% |
| 2022-03-31 | -27.69% |
| 2021-12-31 | -25.66% |
| 2021-09-30 | -23.10% |
| 2021-06-30 | -20.42% |
| 2021-03-31 | -17.15% |
| 2020-12-31 | -14.72% |
| 2020-09-30 | -26.39% |
| 2020-06-30 | -23.20% |
| 2020-03-31 | -34.16% |
| 2019-12-31 | -29.77% |
| 2019-09-30 | -26.98% |
| 2019-06-30 | -24.94% |
| 2019-03-31 | -39.91% |
| 2018-12-31 | -37.26% |
| 2018-09-30 | -31.55% |
| 2018-06-30 | -42.35% |
| 2018-03-31 | -32.79% |
| 2017-12-31 | -41.30% |
| 2017-09-30 | -33.71% |
| 2017-06-30 | -58.74% |
| 2017-03-31 | -50.14% |
| 2016-12-31 | -44.07% |
| 2016-09-30 | -39.04% |
| 2016-06-30 | -35.03% |
| 2016-03-31 | -34.46% |
| 2015-12-31 | -29.03% |
| 2015-09-30 | -44.68% |
| 2015-06-30 | -24.29% |
| 2015-03-31 | -9.67% |
| 2014-12-31 | -2615.04% |
| 2014-09-30 | -1102.51% |
| 2014-03-31 | -357.94% |
| 2013-12-31 | -256.26% |
| 2013-09-30 | -168.63% |
| 2013-06-30 | -131.54% |
| 2012-06-30 | -368.59% |
| 2012-03-31 | -213.42% |
| 2011-09-30 | -4504.57% |
| 2011-06-30 | -583.43% |
| 2011-03-31 | -165.00% |
| 2010-12-31 | -139.53% |
| 2010-09-30 | -962.96% |
